Meloxicam Drug Class
Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) that belongs to the oxicam class and functions as a preferential COX-2 inhibitor. 1
Classification Details
Meloxicam is specifically categorized as a prescription nonselective NSAID in clinical practice guidelines, despite having preferential selectivity for cyclooxygenase-2 (COX-2) over COX-1 1. This classification is important because:
Chemical structure: It is an oxicam derivative (4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1-dioxide) 2
Mechanism: While it preferentially inhibits COX-2, it is not classified alongside the highly selective COX-2 inhibitors like celecoxib (Celebrex), which remains the only pure COX-2 inhibitor available in the U.S. market 1
Clinical positioning: Guidelines list meloxicam under "Prescription Nonselective" NSAIDs rather than with COX-2 inhibitors, reflecting its intermediate selectivity profile 1
Clinical Implications of This Classification
The distinction matters for cardiovascular and gastrointestinal risk stratification:
- Meloxicam carries the standard NSAID black box warning for cardiovascular thrombotic events, myocardial infarction, and stroke 3
- It shares the same GI bleeding risks as other nonselective NSAIDs, with annual rates of 32,000 hospitalizations and 3,200 deaths from NSAID-related GI bleeding in the U.S. 1
- Its preferential COX-2 selectivity may offer some theoretical GI advantage over traditional NSAIDs, but it does not have the distinct risk profile of pure COX-2 inhibitors
In summary: Meloxicam is an NSAID of the oxicam chemical class with preferential (but not highly selective) COX-2 inhibition, classified clinically as a nonselective NSAID for prescribing and risk assessment purposes.